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Abstract.   
Bioprinting is a technology with the prospect to change the way many diseases are treated, by replacing 
the damaged tissues with live, de novo created bio-similar constructs. However, after more than a decade 
of incubation and many proofs-of-concept, the field is still in its infancy. The current stagnation is the 
consequence of its early success: the first bioprinters, and most of those which followed, were modified 
versions of the 3D printers used in additive manufacturing, redesigned for layer-by-layer dispersion of 
biomaterials. In all variants (inkjet, micro-extrusion or laser-assisted), this approach is material-
(‘scaffold’-) dependent and energy-intensive, making it hardly compatible with some of the intended 
biological applications. Instead, the future of bioprinting may benefit from the use of gentler, scaffold-
free bio-assembling methods. A substantial body of evidence has accumulated indicating this is possible 
by use of preformed cell spheroids, which have been assembled in cartilage, bone and cardiac muscle-like 
constructs. However, a commercial instrument capable to directly and precisely ‘print’ spheroids has not 
been available until the invention of the microneedles-based (‘Kenzan’) spheroid assembling, and the 
launching in Japan of a bioprinter based on this method. This robotic platform laces spheroids into pre-
designed contiguous structures with micron-level precision, using stainless steel micro-needles 
(“kenzans’) as temporary support. These constructs are further cultivated until the spheroids fuse into 
cellular aggregates and synthesize their own extracellular matrix, thus attaining the needed structural 
organization and robustness. This novel technology opens wide opportunities for bio-engineering of 
tissues and organs. 
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Introduction.  
  Bioprinting,  a branch of ‘additive (bio)manufacturing’, has evolved as a technology aiming to 
include the third coordinate (3D) into its constructs, and thus making them more biologically-meaningful, 
by adding of multiple 2D layers on top of each other
1
. Apparently, one of the first functional bioprinters 
was a regular printer refurbished to work with ‘bio-matrices’2. The concept of ‘bioink’ is central to the 
bioprinting technology, known as ‘scaffold-assisted’ bioprinting, which relies on the use of a soft 
hydrogel (either alone or containing cells), as cell-supporting matrix
3
.  Correspondingly, the versions of 
this method include ‘inkjet bioprinting’ (with its variants thermal and piezoelectric, depending on how the 
hydrogel droplets are produced), ‘extrusion bioprinting’ (with its pneumatic, piston- and screw-driven 
variants), and ‘laser-assisted bioprinting’ (which uses local melting of a polymeric ‘ribbon’, generating a 
gel droplet which can be deployed with high speed and precision over the construct)
3
.  
Since the ability to perform scaffold-dependent bioprinting mostly depends on the embedding 
material, its properties need to be considered first, rather than those of the cells/tissues to be assembled
4
. 
For this reason, although a large effort has been devoted to find the appropriate scaffold matrices for 
bioprinting, and in spite of good proofs-of-concept
2, 5-7
, only recently instruments based on this 
technology became commercially available. Some bioprinting companies use for their production in-
house built instruments. Others sell bioprinters at the buyer’s own risk, when their claims barely can be 
backed by actual bioprinted constructs or peer-reviewed publications. 
This situation has changed with the invention of a method that does not need exogenous materials, therefore 
belonging to the biomaterial (‘scaffold’)-free category1. As detailed below, in this method the instrument directly 
laces together pre-formed cell spheroids containing tens of thousands of cells on support microneedles
8
. Within 
these spheroids, the cells either have already secreted an extracellular matrix during in vitro formation, or do so 
soon after assembling, thus providing them with robustness and tissue-specific qualities. After an additional in 
situ stage while still attached to their needle support, the spheroids fuse into a compact structure. At this point, the 
constructs are removed and further cultivated during a ‘post-printing maturation’ period, until they acquire more 
of the desired biological qualities. These sequential multiple temporal stages, which are indispensable for the 
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progress of this form of bioprinting towards the final construct, recapitulate basic developmental biology 
(embryological) mechanisms
9
, such as spheroid growth
10
, intra-spheroid cell motility
11
 and layer formation (“cell 
sorting)’12.  
Based on a recent review
1
 commissioned by the journal ‘Biofabrication’ to some of the key 
contributors to the field, the explosive development of this research area is generating terminological 
dilemmas. This consensus study recommended that not all activities generating 3-dimensional constructs 
for tissue engineering be named ‘Bioprinting’. Instead, depending on the technology, some are more 
appropriately named ‘Bio-assembling’,  as both are complementary approaches to ‘Biofabrication’1.   
Besides the notion of ‘scaffold’ (which in this context would indicate a supportive material for 
bioprinting
4, 13-16
), another term with a complex meaning which at times is confusing, is that of ‘bioink’. 
For example, for some authors a ‘bioink’ is whatever is used for bioprinting: any material, cells, or 
combination thereof
16-18
. But for many others, including the companies producing them, the ‘bioinks’ are 
the embedding bio-materials (the ‘scaffolds’) for bioprinting. 
Anticipating these considerations, the Cyfuse company did not name their Regenova robot a ‘3D 
bioprinter’, but rather a ‘Bio 3D-Printer’. Based on the discussion above, this was a good option to signal 
that there is a difference in methodology from the regular scaffold-based 3D bioprinting. From a 
commercial standpoint, this designation also makes sense due to the fact that the target user groups are 
largely the same as with the bioprinting, and because other bio-assembling methods, like the ‘bio-pick, 
place and perfuse’ instrument19, exist although are less known.  
 
1. Limitations of biomaterial-dependent bioprinting.  
The reasons for the limitations of ‘traditional’ bioprinting are derived from several still unsolved 
problems related to the use of a scaffolding material. One is that the material needs to be supportive for all 
cells within a construct, and then for the recipient organism, besides being suitable for the bioprinting 
process per se. Apparently, such an universal material is yet to be found, since often each cell type needs 
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to be embedded in a different hydrogel
5, 20
. Some of these bioinks are in general proprietary, and thus 
unsuitable for further optimization by the user, in addition of being expensive. 
More importantly, the common printing methods are intrinsically stressful to live cells
21
, by exposing 
them to high shear stress, overheating, and/or toxic compounds generated even from initially cell-friendly 
materials
22, 23
. Additionally, the constructs based on hydrogels are by necessity soft, unless the scaffolds 
are made more solid upfront, which is possible only for a limited number of tissues, such as bone and 
cartilage. To deal with this constraint, some research groups incorporate polymeric microfibers within the 
bio-printed structures, a process called ‘hybrid bioprinting’5, 24, 25. This provides the needed sturdiness but 
complicates the other features of a biologically-inspired construct. This is because the native tissue 
architecture, which always contains a degree of structural randomness, can be hardly implemented by 
mechanical means. For this reason, even the more recent bioprinted constructs demonstrate a monotonous 
geometrical design, which only distantly resembles their natural counterparts
5, 6, 20
.  
It is also notoriously difficult to incorporate in these constructs a vascular system, as necessary 
components of tissue-engineered organs capable of long-term functionality. When this was attempted 
within the confines of the current technology, often  rudimentary ‘channels’ were implemented6, 20. Some 
success had the ‘organs-on-chip’ microfluidic devices26, but their scaling-up and integration into 
functional bioprinted constructs need more efforts to succeed. The same issues apply to the innervation of 
the bioprinted constructs
27
.  
Furthermore, dealing with individual cells, the material-dependent bioprinting could be slow, because 
the simplest meaningful structures require millions of cells, which may take a long printing time to be 
added in droplets even when dispensed through high-speed nozzles. Laser-assisted bioprinting can speed 
up the process, but it maintains other limitations (such as heating, cell separation, etc.) in the workflow
28
. 
Also of consideration is that even if printing is performed both gently and fast enough, the ‘encapsulation’ 
of the cells within individual droplets isolates them from their neighbors. To overcome this constraint, the 
cells need to both dissolve their ‘cage’ and/or to proliferate to the point where they can come in direct 
contact.  
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The issue of post-implantation bio-compatibility will acquire new dimensions with every attempted 
clinical application, facing a very close scrutiny for the regulatory agencies, such as the FDA. These are 
justifiably vigilant regarding any materials or substances being either voluntarily or involuntarily 
incorporated in a bioprinted construct. In particular, the xeno-materials are riskier for constructs from 
stem/primitive cells, which could be genetically more unstable and at risk of tumor formation in the 
presence of unusual ‘bio-materials’3. 
 
2. Biomaterial (“scaffold’)-free bioprinting 
Many of the problems above could be collectively eliminated if a biomaterial-free cell assembling 
were available. From the early days of this field it has been appreciated the difficulties generated by the 
use of a ‘scaffold’, and suggested the most rational alternative: using only cells and the matrix they 
secrete
15
. This bioprinting approach was vastly explored conceptually
29
, and computer modeled
17, 30
. The 
attempted implementations use ‘sacrificial’ inorganic materials which permit limited cell-cell interaction, 
then being removed at a point in the process
15
. For example, Organovo’s technology seems to rely on the 
formation of cell strands temporarily supported by ‘fugitive’ (sacrificial) hydrogel cylinders or chopped 
therefrom into shorter fragments, placed in 3D arrangements by a proprietary procedure
31, 32
.  
Another example, emerging from an academic setting, is the preparation of long ‘cellular strands’ in 
alginate tubes
18, 33
. This hydrogel scaffold is then removed and the cell strands re-loaded in a dispensing 
nozzle for extrusion in a layered 3D arrangement. While not truly ‘scaffold free’, this method is however 
a step forward in this direction. Similar cell strands for 3D tissue engineering have been proposed before 
as micro-patterned or as scaffold-wrapped cell cords
34
. However, the central element of biomaterial-free 
methods in tissue engineering is the use of cells in bulk, either as spheroids
35, 36
, cell sheets
37
 or 
cylindrical
15, 38
 cell aggregates, embedded in their own extracellular matrix, and ideally not exposed to 
xeno-materials (such as hydrogels) at any stage of their preparation. The comparative properties of the 
two methods are presented in Table I. 
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3. Cell spheroids as building blocks for bioprinting  
The spheroids as ‘building blocks’ of a bio-fabricated construct can be endowed with a preemptive 
internal cellular organization, reminiscent of that of organoids encountered in developmental biology
10
. 
The pre-formed structures can then be further assembled in larger constructs, operating under the same 
biological laws as the spheroids, rather than under the constraints of bio-materials. 
For example, constructs consisting of about 760 spheroids were made from porcine adipose tissue 
derived stem cells, each containing 5.0×10
4
 autologous cells, and implanted into osteochondral defects (4 
mm in diameter and 6 mm in depth) created in the femoral trochlear groove of adult mini-pigs. The 
histopathology of the implants after 6 months revealed active endochondral ossification underneath the 
smooth hyaline cartilage. After 12 months, not only the diminishing hyaline cartilage was as thick as the 
surrounding normal cartilage, but also a massive subchondral bone was present
39
. 
In another example, a planar construct was made from pulsating spheroids, prepared from three 
human cell types: cardiomyocytes, endothelial cells and fibroblasts
40
. This construct was surgically 
applied in vivo atop of beating rat hearts. It integrated with the epicardium and connected by anastomosis 
of the spontaneously formed capillaries with those of the recipient, documented as the recipient’s blood 
abundantly present within the graft. This proof of concept has now opened the way toward testing more 
complex cardiac patches, and for testing their therapeutic potential. 
Another successful example is the magnetic nanobeads-mediated spheroid formation
41-49
. This 
method (also known as ‘magnetic levitation’ when the cells are collected on top of the fluid in a tissue 
culture well rather than on its bottom
41
), is extremely versatile. It has been used in several high-profile 
studies, being applied for ‘bioprinting’ of complex structures, such as valves48, bronchioles45, or adipose 
tissue
46
. Similar methods are being actively developed in other settings as well
50, 51
. However, among their 
common limitations is the difficulty to place and maintain the spheroids in a pre-determined position, or 
to use spheroids of different compositions and to scale-up to surgically meaningful constructs. For this, 
the authors introduced the use of additional tools, such as a magnetic ‘bio-pen’ which manually could 
bring and keep the spheroids in place 
45, 48
.  
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4. The ‘Kenzan’ method of bioprinting 
To provide the spheroids spatial organization and opportunity to interact and to secrete extracellular 
matrix, thus obtaining a tissue-specific structural organization and biomechanical robustness one of us 
(K.N.) invented the micro-needle based method
8, 39, 40
. It was called ‘Kenzan’ method, after the traditional 
art Ikebana, where for floral arrangements the stalks are impaled in a dome-shaped metal needle array 
called ‘Kenzan’ (in Japanese ken=sword; zan=mountain).  
Unlike other bioprinters which depend on exogenous materials, the instrument that uses the Kenzan 
approach, named Regenova, and commercialized in Japan by Cyfuse Biomedical, K.K., and in US by 
Amuza, Inc., relies only on cells to build complex tissue analogues of practically any composition. The 
cells are first pre-assembled into spheroids, and to provide the spheroids a spatial organization and 
opportunity to interact and to secrete their matrix, they are robotically ‘impaled’ in micro-needles as 
temporary support. The ‘kenzans’ are made of 160 m thick stainless steel microneedles, placed at a 
distance of 500 m (currently available in 2 formats, of 9x9 or 26x26 needles). Therefore, to come in 
contact to each other, the spheroids should be about half-millimeter in diameter (400-600 m), 
representing aggregates of about 20,000 cells or more, depending on the cell type and the degree of 
spheroid compaction. The spheroids are pre-formed in, or transferred into, non-adhesive round-bottomed 
96 well tissue culture plates, from where they are picked up by a nozzle connected to a mobile arm. The 
robot is housed in a ventilated hood with one-way air circulation. During the operation, the front window 
is maintained shut, which permits activity in aseptic conditions.  
The main parts of the Regenova platform are: 
 Plate storage and transport unit; the instrument has two storage magazines, each accommodating 
up to ten 96-well plates, as well as an operation magazine for plate discharge (Fig. 1A). The plates are 
automatically taken from the storage magazine, and transported to the printing area. 
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 Image capture and analysis system. The instrument is equipped with high-quality camera and 
image analysis software which allows the identification of spheroids in the plates (Fig. 1B), as well as the 
needle tips (Fig. 1C). This imaging-based identification also provides a pre-printing quality check for the 
spheroids, those of inappropriate size and/or shape being rejected (the corresponding wells are skipped 
during printing).  
 Kenzan holder. The needle array is submerged in a lidless sterile PBS-filled tank, and secured in a 
holder (Fig. 1D). The mobile nozzle arm carrying a spheroid, contained in a liquid droplet retained by 
capillarity on its tip (Fig. 1E), is moved on top of the needle array (Fig. 1F), and is lowered over it in a 
location determined based on the actual needles position, also obtained by imaging. At that point, the 
negative pressure in the pneumatic system is replaced with a slight positive ‘expiration’, thereby releasing 
the spheroid, and the nozzle is transported back to the plate, to pick up another spheroid.  
       At the bottom of the needle array are two mobile plastic holders (Fig. 1G), which by their sliding 
permit the separation of the construct from the needle support (the second one helps placing in position 
the first ‘separator’ in the needle array for safe re-introduction). The printing process could take 15-20 
min per plate, if the spheroids are well prepared. This allows the rapid, large-scale assembling of 
constructs with multiple pre-designed spheroid layers (Fig. 1H), with as much as 1 cm or more in height 
(Fig. 1I). Using the same structural fusion of live cell aggregates as in spheroids, these proto-tissue blocks 
can be further assembled in even larger constructs, when placed and maintained in contiguity during post-
printing maturation
8
. The smaller needle array also has a hollow configuration where the central needles 
and the bottom are missing (Fig. 1G, middle). This permits its connection to a pump, allowing the 
perfusion with culture medium, during the post-printing maturation of the construct.  
 Spheroid aspiration and printing unit. The main component of this unit is a nozzle with mouth 
comparable to a spheroid’s size, mounted in a holder. This holder is attached to a mobile arm with 
micron-precision 3D positioning control. The slight yet tightly controlled depression used to aspire the 
spheroids is provided by a computer-controlled pump via connectors and a buffer chamber. If the uptake 
of a spheroid fails twice (e.g. due to attachment on well’s bottom or to its inappropriate shape, size or 
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sturdiness), the nozzle holder is moved into a cleaning container where it is purged by air expiration of 
the possible solid contaminants plugging it.  
 Computer system. This provides the integrated remote control, the diagnostic and malfunction 
identification. In addition, the structural design is made available through dedicated software. The 
computer design program called Bio 3D Designer is also available offline for convenient pre-printing 
modeling of the construct geometry (Fig. 1H). 
So far, several publications were based on this technology. For example, live vascular tubes of 2 
cm in length and 5 mm in diameter were printed from spheroids prepared from human endothelial cells, 
smooth muscle cells and fibroblasts
8
. This proto-vessel had enough biomechanical and material resistance 
to sustain surgical manipulations and suturing. When they were implanted in immuno-deficient rats into 
abdominal aorta and retrieved after 5 days, these cellular tubes showed maintenance of structural integrity 
and patency, without thrombosis and displaying a continuous endothelium of donor origin. However, 
given the low proportion of smooth muscle cells and lack of organized extracellular matrix (i.e., elastic 
laminae) at the time of printing, all grafts remodeled with enlargement of the lumen area and thinning of 
the wall
8
. Results with other constructs were also made available as posters at scientific conferences, e.g. 
tracheal
52
 or urethral
53
 tubes.  
  
5. Specifics and adjustments of the Kenzan method  
Being essentially a spheroid-assembling method, the efficiency and quality of Kenzan bioprinting is 
directly dependent on that of its building blocks. Below we are summarizing some of the spheroid-related 
properties of this method. 
Spheroid size is determined by the inter-needle distance. The fixed inter-needle distance and the 
need to put them in contact, makes the size of usable spheroids fall in a relatively narrow range. For this 
reason, the user has to master the technique of generating optimal spheroids before coming to the printer. 
While for small-scale, routine constructs this is usually trivial, there are instances when new cell 
combinations, longer (or too short) incubation times, or tissue culture factors, can make the spheroid 
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dimensions unpredictable or sub-optimal. In addition, some constructs may not be made at the scale 
requested for direct Kenzan assembling. In this case, a solution would be to pre-incorporate the desired 
cellular structures in ‘supporting’ spheroids with a generic compositions (such as fibroblasts and 
endothelial cells, for example). 
Related to the size is the need to optimize the time to keep the spheroids in culture for adequate 
extracellular matrix secretion (see below). This is constrained by the diffusion limit of oxygen (usually 
200 m in vivo), or by that of glucose or other nutrients. The spheroid cores could thus be deprived of 
nutrients if maintained too long in culture. While for more primitive cells hypoxia might be advantageous, 
for differentiated cells these conditions could be detrimental, making the spheroids fragile at the printing 
stage and/or during the post-printing maturation.  
Another consideration is the localization within the bulk of spheroidal space of cells of an 
epithelial phenotype. This raises a topological dilemma, because these cells are supposed to stay on a 
surface. While for endothelial cells this location is less consequential (these cells being capable to easily 
switch between a cord-like arrangement in pre-capillaries to tubular structures in capillaries), for a bona-
fide epithelium an intra-spheroid arrangement is less meaningful. As an alternative, these cells can be 
cultivated on the surface of spheroid by secondary attachment, or on the surface of hydrogel beads. 
Spheroids for printing need a balanced cell-cell interaction and extracellular matrix composition. 
Essential for the spheroids formation are their direct inter-cellular interactions
14
. At the same time, for all 
subsequent practical applications, a robust extracellular matrix is also crucial. In particular, the stability of 
the spheroids at the printing stage requires a balance between cell adhesiveness and matrix abundance, 
which may reduce the strength of direct intercellular adhesive forces by interposition, but gives better 
material properties. During the spheroid formation these two processes change in opposing directions, 
adhesiveness decreasing while the extracellular matrix deposition increases. If we add to this that cell 
survival at the core of the spheroid is also likely to be reduced with time in culture, we have a complex 
picture of how the spheroids need to be optimized when brought to Kenzan bioprinting. 
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Cell distribution within spheroids undergoes a continuous re-arrangement. Also relevant is the 
actual distribution, proliferation, etc. of cells in heterogeneous spheroids. As extensively shown in 
developmental biology studies, far from remaining randomly distributed, the cells tend to associate 
among themselves in more structured arrangements (e.g. layers), by preferentially partnering with those 
which are similar. Actually, the stronger-interacting cells tend to occupy the core, and the others distribute 
themselves in concentric layers, in the decreasing order of adhesive strength. This simple process called 
‘cell separation’, is one of the fundamental mechanisms driving early development54. In larger artificial 
spheroids, this could be combined with a limited nutrient diffusion, making the cell type that tends to 
settle at the center to suffer more from a limited nutrient diffusion and to enter apoptosis, which may 
change in time the cell proportions and thus spheroid properties.  
Consequences of spheroids compaction. Inside spheroids the cells move within the limits 
imposed by the available space, and by the intercellular adhesions. This process, combined with the 
deposition of extracellular matrix, is beneficial for the ‘healing’ of the holes left behind by the needles. 
However, if the goal is to print tubes or other hollow structures, this contraction may lead to their 
premature disappearance, which would need additional stabilization.  Also, spheroid compaction may 
lead to sub-optimal physiological conditions at the core, i.e. reduced oxygen and metabolite diffusion, and 
from here reduced strength of adhesive forces between cells.  
 
6. Conclusions  
Bioprinters conceived so far were mostly adaptations of regular 3D printers for layer-by-layer additive 
bio-manufacturing, i.e. dispersers of ‘bioinks’ containing or not live cells. Bioinks as droplets or slurries of bio-
materials which during printing undergo heating, vibration, extrusion, or other energy-intensive processes, could 
be hardly bio-compatible with the needs of the contained cells, or with those of the recipient organism. For these 
reasons, with the exception of several prototypes operated in academic or corporate laboratories and of few 
commercial instruments, the larger community of investigators still has limited access to efficient bioprinting 
technology to serve their research needs.  
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 The power of spheroid-based tissue engineering is now materialized in the Kenzan method and the 
commercial Regenova bioprinter, the instrument capable to put this approach in practice.  Besides avoiding the 
shortcomings of bioinks, another of its benefits is similarity with certain aspects of developmental and tumor 
biology, routinely ignored or unaccounted for in biomaterial-assisted bioprinting. In spheroids many well-known 
bio-physical and biological mechanisms are involved, which can be rationally incorporated and more efficiently 
exploited for tissue engineering purposes. 
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Figure 1. Main components of the Regenova bioprinting platform. A. Aseptic hood containing the 
assembling line: a plate storage magazine (far left), followed by two feeding magazines and a plate 
transportation line towards the mobile arm (far right) and an imaging system (red light). B. Cell spheroid 
imaged within its feeding plate’s well. C. Top view of a completed cell construct and the tips of 
supporting micro-needles. D. Fluid-immersed Kenzan holder. E. Nozzle aspirating a spheroid. F. Nozzle 
depositing a spheroid onto a needle. G. Three types of Kenzans (with 9x9 regular and hollow, and with 
26x26 needles); note the needle-perforated plastic bases. H. A virtual double-layered tube created with 
the ‘Bio 3D Designer’ program. I. An actual spheroid constructs awaiting post-printing maturation. 
Images courtesy of Cyfuse Biomedical K.K. 
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  BIOMATERIAL-DEPENDENT  BIOMATERIAL-FREE  
  
  
 Attributes Comments  Attributes  Comments 
OBJECT 
CONFIGURATION 
Direct image input 
via CAD 
Similar to 3D printing Approximate 
Larger ‘voxel’ size, 
limited resolution  
STRUCTURAL  
COHESION 
(‘glue’) 
Obtained by non-
universal, 
sometimes 
proprietary and/or 
expensive bio-inks  
New biological bio-
inks emerging (e.g. 
collagen or fibrin 
based) 
Cells produce 
their own matrix; 
constructs are 
dependent on cell 
type and quality 
Matrix deposition can 
be unpredictable or 
insufficient 
BIOMECHANICS 
Hydrogels are 
essentially soft; 
hardening can be 
cell-damaging  
‘Hybrid’ bioprinting 
as alternative: 
incorporation of a 
second (fibrillar) 
biomaterial 
Construct 
biomechanics 
less predictable 
and controllable  
Hybrid versions are 
also likely to be 
developed 
EFFICIENCY 
Substantial cell 
death, for a variety 
of method-specific 
reasons  
Milder methods are 
being tested (e.g. 
laser-assisted 
bioprinting) 
Less or no cell 
damage 
Cell-type 
dependent  
By using large 
spheroids, speed can 
become comparable or 
even higher than laser-
assisted bioprinting 
CELLULAR  
CROSS-TALK 
Material-limited inter-
cellular 
communication 
(‘encapsulation’)  
Not a problem for 
matrix-rich tissues 
such as bone, 
cartilage 
Direct cellular 
interactions 
Optional addition of 
hydrogels into or 
between spheroids still 
possible 
TISSUE  
STRUCTURE 
Simplistic cellular 
architecture   
Biomaterial 
dissolution allows 
more spontaneous 
cell rearrangements 
Follows 
developmental 
principles  
Incorporation of 
endothelial cells in 
spheroids may promote 
micro-vascularization 
BIO-
COMPATIBILITY 
Cytotoxicity possible, 
foreign-body 
reactions likely 
Less serious if 
biological bio-inks 
are used 
Patient-specific 
cells: MSC, iPSC 
Possibly fully 
autologous constructs 
COMMON 
TECHNICAL 
PROBLEMS 
Nozzle clogging 
Limited to ink-jet and 
micro-extrusion 
methods 
Time of pre-
printing 
preparations 
Post-printing maturation 
time comparable 
between the two 
approaches 
SCALABILITY Excellent 
Good for large, 
cell-homogenous,  
matrix-rich tissues                                          
More limited 
Recommended for 
small, cell-
heterogeneous, 
matrix-poor tissues 
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